Europe Cold Sore Treatment Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Mar 2021
  • Europe
  • 350 Pages
  • No of Tables: 237
  • No of Figures: 47

Europe Cold Sore Treatment Market, By Strain Type (Herpes Simplex Type-1 Virus and Herpes Simplex Type-2 Virus), Therapeutics (Antiviral Agents, Analgesic Agents and Others), Drug Type (Branded and Generic), Dosage Type (Oral, Topical and Others), End User (Hospitals, Homecare, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others), Country (Germany, U.K., France, Italy, Belgium, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe) Industry Trends and Forecast to 2028

Europe Cold Sore Treatment Market Market Analysis and Insights: Europe Cold Sore Treatment Market

Cold sore treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.9% in the forecast period of 2021 to 2028 and is expected to reach USD 273.12 million by 2028 from USD 176.72 million in 2021.

Rising prevalence of Herpes simplex virus (HSV) globally and proliferation in modes of transmission of HSV are the major drivers which propelled the demand of the market in the forecast period.

Cold sores or oral herpes are small blisters like abrasions that occur due to the infection caused by the Herpes simplex virus (HSV). Cold sores generally occur on the face, around the lips, chin, cheeks, and nostrils. They generally cause pain, itching before they burst. HSV is one of the most common viruses found to affect the global population and it is endemic throughout the world. Up to 90% of people around the world have at least one form of HSV.

Herpes Simplex Virus (HSV) generally infects the pediatric population worldwide, but according to WHO, people aged 30-49 are at higher risk now for catching the virus, and the prevalence of HSV increases with age. HSV has two types: HSV type-1, and HSV type-2. HSV-1 causes cold sores or oral herpes around lips, nostrils, and cheeks. While HSV-2 cause’s genital herpes. HSV can be spread through the direct mode of transmission which includes oral contact inducing infection with oral herpes, from oral to skin surfaces that appear normal and when there is no symptom present.

The cold sore treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Cold Sore Treatment Market Europe Cold Sore Treatment Market Scope and Market Size

The cold sore treatment market is categorized into six notable segments which are based on the strain type, therapeutics type, drug type, dosage type, end user and distribution channel.

  • On the basis of strain type, the cold sore treatment market is segmented into herpes simplex type-1 virus, and herpes simplex type-2 virus. In 2021, Herpes simplex type-1 virus (HSV), segment is dominating the market due to its rapidly increasing prevalence.
  • On the basis of therapeutics type, the cold sore treatment market is segmented into antiviral agents, analgesic agents, and others. In 2021, antiviral segment is expected to dominate the cold sore treatment market due to the increased count of infectious diseases caused by herpes simplex virus and enhanced product pipeline in antiviral agents are predicted to dominate the market.
  • On the basis of drug type, the cold sore treatment market is segmented into branded and generics. In 2021, generics is dominating the cold sore treatment market because it’s very less expensive as compared to branded drugs, and due to the economical nature, and increased usage for the treatment of cold sores globally.
  • On the basis of dosage type, the cold sore treatment market is segmented into oral, topical, and others. In 2021, oral segment is expected to dominate the cold sore treatment market because of its ease of absorption and flexibility to accommodate various types of drugs.
  • On the basis of end user, the cold sore treatment market is segmented into hospitals, homecare, specialty clinics, and others. In 2021, homecare segment is dominating the market due to the ease in treatment at home and easy availability of drugs.
  • On the basis of distribution channel, the cold sore treatment market is segmented into hospital pharmacy, retail pharmacy and online pharmacy. In 2021, hospital pharmacy is expected to dominate the market due to the rise in access to cold sore medications and surge in number of prescriptions of cold sore medications on a daily basis are predicted to dominate the market.

Cold Sore Treatment Market Country Level Analysis

The cold sores treatment market is analysed and market size information is on basis of country, strain type, therapeutic uses, drugs type, dosage type, end user, and distribution channel.

The countries covered in the Cold sores treatment market report are Germany, U.K., France, Italy, Belgium, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe.

Germany in Europe is expected to grow with the most promising growth rate in the forecast period of 2021 to 2028 due to the increasing very rapidly due to rapidly increasing patient population and advancements in technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Strategic Initiatives by Manufactures is Creating New Opportunities for Players in the Cold Sore Treatment Market 

Cold sore treatment market also provides you with detailed market analysis for every country growth in aesthetic industry with Cold sore treatment sales, impact of advancement in the Cold sore treatment and changes in regulatory scenarios with their support for the Cold sore treatment market. The data is available for historic period 2011 to 2019.  

Competitive Landscape and Cold Sore Treatment Market Share Analysis

Cold sore treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to cold sore treatment market.

The major companies dealing in the market are  Merix Pharmaceutical Corp., GlaxoSmithKline plc, Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceutical Inc., U.S.A. (A subsidiary OF Glenmark Pharmaceuticals Ltd.), Zydus Pharmaceuticals, Inc.(A Subsidiary of Zydus Cadila), Cipla Inc., AiCuris, Ortho dermatologics’ (a division of bausch health Companies Inc.), Foundation Consumer Healthcare, Squarex, Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.) , Aurobindo Pharma U.S.A.  (A Subsidiary of Aurobindo Pharma), WOCKHARDT, Novartis AG, Jubilant Cadista (a subsidiary of Jubilant Life Sciences Limited), Hikma Pharmaceuticals PLC, Hetero Healthcare Limited, Apotex Inc., Avanir Pharmaceuticals, Inc., HRA Pharma, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the cold sore treatment market.

  • In May 2020, Teva Pharmaceutical Industries Ltd. reported that the 2020 annual meeting of shareholders will be held online by looking at the COVID-19 scenario and in the interest of health and safety of its shareholders, directors, officers and employees. This will help in creating and discussing strategies for the coming year.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the Cold sore treatment market which also provides the benefit for organisation to improve their offering for Cold sore treatment.  

Customization Available: Europe Cold Sore Treatment Market  

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 EUROPECOLD SORE TREATMENT MARKET, PIPELINE ANALYSIS

TABLE 2 GENERIC DRUGS USED FOR THE TREATMENT OF HSV (COLD SORES)

TABLE 3 EUROPE COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 4 EUROPE HERPES SIMPLEX TYPE 1 VIRUS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 EUROPE HERPES SIMPLEX TYPE 2 VIRUS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 EUROPE COLD SORE TREATMENT MARKET, BY THERAPEUTICS 2019-2028 (USD MILLION)

TABLE 7 EUROPE ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY REGION 2019-2028 (USD MILLION)

TABLE 8 EUROPE ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 9 EUROPE ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 EUROPE ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 11 EUROPE OTHERS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 EUROPE COLD SORE TREATMENT MARKET, BY DRUG TYPE 2019-2028 (USD MILLION)

TABLE 13 EUROPE GENERICS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 EUROPE GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 15 EUROPE BRANDED IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 EUROPE BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 17 EUROPE COLD SORE TREATMENT MARKET, BY DOSAGE TYPE 2019-2028 (USD MILLION)

TABLE 18 EUROPE ORAL IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 EUROPE ORAL SEGMENT IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 20 EUROPE TOPICAL SEGMENT IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 EUROPE TOPICAL SEGMENT IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 22 EUROPE OTHERS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 EUROPE COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 24 EUROPE HOSPITALS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 EUROPE HOSPITALS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 EUROPE SPECIALTY CLINICS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 EUROPE OTHERS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 EUROPE COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 29 EUROPE HOSPITALS PHARMACY IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 EUROPE ONLINE PHARMACY IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 EUROPE RETAIL PHARMACY IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 EUROPE COLD SORE MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 33 EUROPE COLD SORE MARKET, BY STRAIN, 2019-2028 (USD MILLION)

TABLE 34 EUROPE COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 35 EUROPE ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 36 EUROPE ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 37 EUROPE COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 38 EUROPE GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 39 EUROPE BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 40 EUROPE COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 41 EUROPE ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 42 EUROPE TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 43 EUROPE COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 44 EUROPE COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 45 GERMANY COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 46 GERMANY COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 47 GERMANY ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 48 GERMANY ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 49 GERMANY COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 50 GERMANY GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 51 GERMANY BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 52 GERMANY COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 53 GERMANY ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 54 GERMANY TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 55 GERMANY COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 56 GERMANY COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 57 FRANCE COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 58 FRANCE COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 59 FRANCE ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 60 FRANCE ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 61 FRANCE COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 62 FRANCE GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 63 FRANCE BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 64 FRANCE COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 65 FRANCE ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 66 FRANCE TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 67 FRANCE COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 68 FRANCE COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 69 U.K. COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 70 U.K. COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 71 U.K. ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 72 U.K. ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 73 U.K. COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 74 U.K. GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 75 U.K. BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 76 U.K. COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 77 U.K. ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 78 U.K. TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 79 U.K. COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 80 U.K. COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 81 ITALY COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 82 ITALY COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 83 ITALY ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 84 ITALY ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 85 ITALY COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 86 ITALY GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 87 ITALY BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 88 ITALY COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 89 ITALY ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 90 ITALY TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 91 ITALY COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 92 ITALY COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 93 SPAIN COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 94 SPAIN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 95 SPAIN ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 96 SPAIN ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 97 SPAIN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 98 SPAIN GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 99 SPAIN BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 100 SPAIN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 101 SPAIN ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 102 SPAIN TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 103 SPAIN COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 104 SPAIN COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 105 RUSSIA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 106 RUSSIA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 107 RUSSIA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 108 RUSSIA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 109 RUSSIA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 110 RUSSIA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 111 RUSSIA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 112 RUSSIA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 113 RUSSIA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 114 RUSSIA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 115 RUSSIA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 116 RUSSIA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 117 SWITZERLAND COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 118 SWITZERLAND COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 119 SWITZERLAND ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 120 SWITZERLAND ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 121 SWITZERLAND COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 122 SWITZERLAND GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 123 SWITZERLAND BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 124 SWITZERLAND COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 125 SWITZERLAND ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 126 SWITZERLAND TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 127 SWITZERLAND COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 128 SWITZERLAND COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 129 NETHERLAND COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 130 NETHERLAND COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 131 NETHERLAND ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 132 NETHERLAND ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 133 NETHERLAND COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 134 NETHERLAND GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 135 NETHERLAND BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 136 NETHERLAND COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 137 NETHERLAND ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 138 NETHERLAND TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 139 NETHERLAND COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 140 NETHERLAND COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 141 TURKEY COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 142 TURKEY COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 143 TURKEY ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 144 TURKEY ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 145 TURKEY COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 146 TURKEY GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 147 TURKEY BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 148 TURKEY COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 149 TURKEY ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 150 TURKEY TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 151 TURKEY COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 152 TURKEY COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 153 IRELAND COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 154 IRELAND COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 155 IRELAND ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 156 IRELAND ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 157 IRELAND COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 158 IRELAND GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 159 IRELAND BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 160 IRELAND COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 161 IRELAND ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 162 IRELAND TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 163 IRELAND COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 164 IRELAND COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 165 BELGIUM COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 166 BELGIUM COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 167 BELGIUM ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 168 BELGIUM ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 169 BELGIUM COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 170 BELGIUM GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 171 BELGIUM BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 172 BELGIUM COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 173 BELGIUM ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 174 BELGIUM TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 175 BELGIUM COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 176 BELGIUM COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 177 POLAND COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 178 POLAND COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 179 POLAND ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 180 POLAND ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 181 POLAND COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 182 POLAND GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 183 POLAND BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 184 POLAND COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 185 POLAND ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 186 POLAND TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 187 POLAND COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 188 POLAND COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 189 AUSTRIA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 190 AUSTRIA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 191 AUSTRIA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 192 AUSTRIA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 193 AUSTRIA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 194 AUSTRIA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 195 AUSTRIA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 196 AUSTRIA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 197 AUSTRIA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 198 AUSTRIA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 199 AUSTRIA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 200 AUSTRIA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 201 NORWAY COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 202 NORWAY COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 203 NORWAY ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 204 NORWAY ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 205 NORWAY COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 206 NORWAY GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 207 NORWAY BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 208 NORWAY COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 209 NORWAY ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 210 NORWAY TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 211 NORWAY COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 212 NORWAY COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 213 HUNGARY COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 214 HUNGARY COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 215 HUNGARY ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 216 HUNGARY ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 217 HUNGARY COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 218 HUNGARY GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 219 HUNGARY BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 220 HUNGARY COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 221 HUNGARY ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 222 HUNGARY TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 223 HUNGARY COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 224 HUNGARY COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 225 LITHUANIA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 226 LITHUANIA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 227 LITHUANIA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 228 LITHUANIA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 229 LITHUANIA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 230 LITHUANIA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 231 LITHUANIA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 232 LITHUANIA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 233 LITHUANIA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 234 LITHUANIA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 235 LITHUANIA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 236 LITHUANIA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 237 REST OF EUROPE COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions